Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
1. Most glove maker capacity full till mid 2021, some even upto 1 year delivery time with payment upfront. Contract manufacturing price USD85/kpcs & Spot price is USD180/kpcs.
2. Most manufacturing cost is less than USD20/kpcs even with increased in raw material cost.
3. Current ASP price of USD85 has 425% profit margin and expected to maintain till end of 2021.
4. Even using pre-covid19 price of USD35/kpcs, it still has 75% profit margin.
5. Using ATG projected output capacity of 211mil/month X 12 months = 2.5bil X USD85/kpcs = USD215,220,000/year X 425% profit = USD914,685,000 (RM3.841 bil profit).
6. Carepls share price at RM3.80 with Q220's revenue of RM118,898,000, having PE61.89. With AT revenue of RM223,125,000/qtr, it's share price at PE61.89 could fetch RM7.13/share. Even at PE10, it's share price could fetch RM1.18.
7. Carepls price surged from RM0.17 in Jan 20 and peaked RM5.37 in Aug 20, an increase of 31X fold in 8 months. At 31X fold, AT current price at 0.08 could possibly peak at RM2.48.
Disclaimer : The above calculation is base on ASP of USD85/kpcs and 2.5bil capacity output. The benchmark and assumption are forward looking and past performance that may not be representative of actual and future performance. This is for educational purpose, not a buy or sell call. Always do your research before trade at your own risk.
ermmmm cannot compare K+ oh ....they have more than 10 years in this field ....and have establish a footprint in the glove market with ansell .... AT still have a long way to go
Remember stock market is about investor confidence. The only way now is to show that plant is kick off production or pearl glove acqusition is materialized.
